SHUTTLE PHARMACEUTICALS HOLD
SHPH · NASDAQ
Updated at 2026-10-13 12:11:24
- Today's High
- --
- Today’s Low
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $5.36
- Previous Close
- $5.45
- Volume
- 21.39K
- Market Cap
- $25.96M
- P/E Ratio
- --
- EPS
- $-27.51
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 401 PROFESSIONAL DRIVE, GAITHERSBURG, MD, UNITED STATES, 20879
- Country
- US
- Listing Date
- 2022-08-31
- Fiscal Year End
- December
- Shares Outstanding
- 640K
- CIK
- 0001757499
- Website
- shuttlepharma.com
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of drugs to sensitize cancers to radiation therapy. The company is headquartered in Rockville, Maryland.
Financial Metrics
Revenue
2026-06-30
--
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.94M
2026-03-31
$1.58M
2025-12-31
$2.49M
2025-09-30
$2.26M
Net Income
2026-06-30
-$3.14M
2026-03-31
-$2.15M
2025-12-31
-$2.61M
2025-09-30
-$2.34M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-3.84
2026-03-31
$-4.27
2025-12-31
$-12.92
2025-09-30
$-1.05
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.31M
2026-03-31
-$1.5M
2025-12-31
-$2.3M
2025-09-30
-$2.32M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | -- | $0 | $0 | $0 |
| Operating Expenses | $3.94M | $1.58M | $2.49M | $2.26M |
| Net Income | -$3.14M | -$2.15M | -$2.61M | -$2.34M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-3.84 | $-4.27 | $-12.92 | $-1.05 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.31M | -$1.5M | -$2.3M | -$2.32M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.